These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 3280991)

  • 21. Salmonella mutagenicity of musk ambrette depends on both microsomal and bacterial enzyme activity.
    Mersch-Sundermann V; Emig M
    Anticancer Res; 1998; 18(2A):829-31. PubMed ID: 9615727
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Study on the mutagenicity of nifurtimox and eight derivatives with the L-arabinose resistance test of Salmonella typhimurium.
    Alejandre-Durán E; Claramunt RM; Sanz D; Vilaplana MJ; Molina P; Pueyo C
    Mutat Res; 1988 Oct; 206(2):193-200. PubMed ID: 3050499
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolic reduction of novel 3,4-dichloro-5-nitrofurans in Salmonella typhimurium.
    Hatcher JF; Yamamoto K; Ichikawa M; Bryan GT; Swaminathan S
    Environ Mol Mutagen; 1995; 25(1):58-66. PubMed ID: 7875127
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relative importance of bacterial and mammalian nitroreductases for niridazole mutagenesis.
    Blumer JL; Friedman A; Meyer LW; Fairchild E; Webster LT; Speck WT
    Cancer Res; 1980 Dec; 40(12):4599-605. PubMed ID: 6893679
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutagenicity of nitracrine analogues in Salmonella typhimurium: mutational specificity and activation by bacterial enzymes and rat-liver S9.
    Ferguson LR; Turner PM; Denny WA
    Mutat Res; 1987 Jan; 187(1):1-9. PubMed ID: 3540655
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutagenicity of nitrofurans in Salmonella typhimurium TA98, TA98NR and TA98/1,8-DNP6.
    Ni YC; Heflich RH; Kadlubar FF; Fu PP
    Mutat Res; 1987 Sep; 192(1):15-22. PubMed ID: 3309641
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutagenicity of the phenolic microsomal metabolites of 3-nitrofluoranthene and 1-nitropyrene in strains of Salmonella typhimurium.
    Consolo MC; Anders M; Howard PC
    Mutat Res; 1989 Feb; 210(2):263-9. PubMed ID: 2643025
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies on pentane evolution by rats treated with nifurtimox or benznidazole.
    Castro GD; Castro JA
    Toxicology; 1985 Jun; 35(4):319-26. PubMed ID: 4012799
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The mutagenicity on Salmonella typhimurium of nitrobenzoic acids and other wastewater components generated in the production of nitrobenzoic acids and nitrotoluenes.
    Sundvall A; Marklund H; Rannug U
    Mutat Res; 1984; 137(2-3):71-8. PubMed ID: 6381997
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nitroreduction of benznidazole and nifurtimox by rat and human feces.
    de Toranzo EG; Masana M; Castro JA
    Res Commun Chem Pathol Pharmacol; 1983 Aug; 41(2):341-4. PubMed ID: 6688884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of phenanthrene to mutagenic metabolites and evidence for at least two different activation pathways.
    Oesch F; Bücker M; Glatt HR
    Mutat Res; 1981 Mar; 81(1):1-10. PubMed ID: 7019683
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of the mutagenicity of three dinitropyrene isomers in vitro by rat-liver S9, cytosolic, and microsomal fractions following chronic ethanol ingestion.
    Winston GW; Traynor CA; Shane BS; Hajos AK
    Mutat Res; 1992 Jun; 279(4):289-98. PubMed ID: 1377785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutagenicity studies with nitrofurans. II. mutagenicity of nitrofurylacrylic acid for Salmonella typhimurium.
    Cerná M; Srám RJ
    Mutat Res; 1980 Jan; 77(1):1-12. PubMed ID: 6987507
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutagenicity of the phenacetin metabolites: N-hydroxy-p-phenetidine and nitrosophenetol in S. typhimurium TA100 and derivatives deficient in nitroreductase or O-acetylase: probes for testing intrabacterial metabolic activation.
    McCoy EC; Rosenkranz HS; Bartsch H
    Mutat Res; 1986 Apr; 173(4):245-50. PubMed ID: 3513003
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Restricted bioreductive metabolism of a nitroimidazole-thiadiazole derivative with curative action in experimental Trypanosoma cruzi infections.
    Tsuhako MH; Alves MJ; Colli W; Brener Z; Augusto O
    Biochem Pharmacol; 1989 Dec; 38(24):4491-6. PubMed ID: 2513811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of mutagenicity and theoretical reactivity of 2,4-dinitrobenzaldehyde and 2,6-dinitrobenzaldehyde in bacterial mutation assay and molecular orbital method.
    Sayama M; Mori M; Shinoda H; Kozuka H
    Mutat Res; 1990 Jan; 243(1):47-52. PubMed ID: 2405266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Specificity and sensitivity of Salmonella typhimurium YG1041 and YG1042 strains possessing elevated levels of both nitroreductase and acetyltransferase activity.
    Hagiwara Y; Watanabe M; Oda Y; Sofuni T; Nohmi T
    Mutat Res; 1993 Jun; 291(3):171-80. PubMed ID: 7685058
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutagenicity of 30 chemicals in Salmonella typhimurium strains possessing different nitroreductase or O-acetyltransferase activities.
    Einistö P; Watanabe M; Ishidate M; Nohmi T
    Mutat Res; 1991 Jan; 259(1):95-102. PubMed ID: 1988826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutagenic activity of dichloroethylamino derivatives of nitronaphthofuran and some nitrobenzofurans in the Salmonella/microsome assay.
    Castelain P; Hendrickx B; Tromelin A; Demerseman P; Moens W
    Mutat Res; 1992 Jul; 280(1):9-15. PubMed ID: 1377347
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutagenicity of CL 64855, a potent anti-Trypanosoma cruzi drug.
    Ferreira RC; Ferreira LC
    Mutat Res; 1986 Jul; 171(1):11-5. PubMed ID: 3523230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.